CD4 and myeloid sarcoma: Furthermore, the respective HLA-DRB1*1501 restricted CD4+ T cells that recognize EBV transformed B cells (lymphoblastoid cell lines or LCL) cross-react with myelin basic protein (MBP), an autoantigen in MS.